Added the source-verified Claim Check to the structured claim/source/change registry.
Source record · Small human mechanistic studies and FDA review · reviewed July 18, 2026
Human mechanistic evidence exists. A clinically proven productivity or memory benefit does not.
The circulating claim“Semax is clinically proven to improve focus, memory, and productivity.”
What the source record says
Small human studies measured resting-state brain connectivity after intranasal Semax. They did not establish improved daily function, memory, or productivity, and FDA found the clinical evidence insufficient for the nominated medical uses.
Why the claim misleads
A small brain-imaging signal is being translated into broad real-world cognitive outcomes that the studies did not measure.
Correction
Human mechanistic evidence exists. A clinically proven productivity or memory benefit does not.
Primary sources
FDA Semax briefing document, 2026Open source ↗Lebedeva et al., 2018 — healthy-volunteer fMRI studyOpen source ↗Panikratova et al., 2020 — resting-state connectivity studyOpen source ↗Semax library entryOpen source ↗What changed
What would change our answer
A well-controlled human study tied to the exact product, population, route, and claimed outcome could change the answer. Mechanism, anecdotes, or a different product cannot substitute for that evidence.
Version history · 1 entry
- v1 · 2026-07-18Initial structured record created from the reviewed Claim Check.Source ↗
Boundary: This check evaluates a public claim. It does not assess an individual product or person and is not treatment, dosing, sourcing, or legal advice.